In addition, we found that ginsenosides, as the inhibitors of TMPRSS2, play different roles in lung cancer and COVID-19 patients, providing new insights into the prevention and treatment of COVID-19 in lung cancer patients. Here, TMPRSS2 is linked to lung carcinoma.